Investors renew interest in biotech amid sluggish economy

11/14/2012 | Nature

A dozen biotech firms have floated initial public offerings so far this year, and the stocks have outperformed the Nasdaq Composite Index since the first quarter of 2011. IPOs can help young companies survive and expand research capacity, and rising confidence can attract money from investors who do not specialize in health care. An overall sluggish economy might be helping the biotech sector, where "earnings tend to grow independently of the economy, unlike electronics or consumer products," said Eric Schmidt, an analyst at investment bank Cowen and Company.

View Full Article in:

Nature

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX